Septerna president and COO Elizabeth Bhatt sells $149,644 in stock

Elizabeth Bhatt, President and Chief Operating Officer of Septerna, Inc., sold a substantial amount of her company's stock on October 15, 2026. Specifically, she traded 4,000 shares, totaling $149,644, at a weighted average price of $36.98 per share. This sale was executed under a pre-established Rule 10b5-1 sales plan, which Bhatt had previously approved on October 20, 2025.

The current trading price for Septerna's stock stands at $36.34, reflecting robust market performance with a year-over-year gain of 65% and a six-month increase of 39%, according to InvestingPro data. In a separate transaction on the same day, Bhatt also purchased 4,000 shares of Septerna common stock through the exercise of stock options, paying $6.81 per share, amounting to $27,240.

These options are part of a compensation package where she will receive the shares in 1/48th increments over time, contingent on her continued employment at the company. After these transactions, Bhatt now owns a total of 174,209 shares of Septerna stock and 58,230 stock options. Septerna Inc has been garnering attention from various analyst firms due to advancements in its Phase 1 trial for an oral PTH1R agonist, SEP-479, aimed at treating hypoparathyroidism.

Recent upgrades from H.C. Wainwright, Stifel, and Guggenheim have increased investor confidence, pointing to potential growth in the pharmaceutical sector.